By Julie S. Keenan
SCOTTSDALE, Ariz. — Lack of standardized labels for marijuana products in the United States can lead to poor kidney outcomes, according to a presenter at the Southwest Nephrology Conference.
Laura Wicks, PharmD, BCPS, an acute care clinical pharmacy specialist from Banner University Medical Center in Phoenix, detailed the current legality of marijuana, the impact the drug can have on patients and what can be done about the lack of standardized labels on marijuana products. Read more in Healio.